Dermatitis, Contact

Dermatology
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
Organic, Unrefined Coconut OilN/A1 trial
Active Trials
NCT02614248CompletedEst. Jun 2019
Pfizer
PfizerNEW YORK, NY
1 program
Tablet MethylprednisoloneN/A1 trial
Active Trials
NCT00929981Completed80Est. Sep 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Genesis TherapeuticsOrganic, Unrefined Coconut Oil
PfizerTablet Methylprednisolone

Clinical Trials (2)

Total enrollment: 80 patients across 2 trials

NCT02614248Genesis TherapeuticsOrganic, Unrefined Coconut Oil

The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population

Start: Jan 2016Est. completion: Jun 2019
N/ACompleted
NCT00929981PfizerTablet Methylprednisolone

A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

Start: Sep 2009Est. completion: Sep 201080 patients
N/ACompleted

Related Jobs in Dermatology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space